Advanced search
Publication Cover
Expert Review of Vaccines Volume 11, 2012 - Issue 11
Submit an article Journal homepage
121
Views
14
CrossRef citations to date
0
Altmetric
Perspective

Resolving pertussis immunity and vaccine effectiveness using incidence time series

Jennie S Lavine Department of Ecology and Evolutionary Biology, University of Michigan, Ann Arbor, MI 48109, USA; Fogarty International Center, National Institutes of Health, Bethesda,MD 20892, USA; Department of Ecology and Evolutionary Biology, University of Michigan, Ann Arbor, MI 48109, USA. [email protected]
&
Pejman Rohani Department of Ecology and Evolutionary Biology, University of Michigan, Ann Arbor, MI 48109, USA; Fogarty International Center, National Institutes of Health, Bethesda,MD 20892, USA; Center for the Study of Complex Systems, University of Michigan,Ann Arbor, MI 48109, USA; Department of Ecology and Evolutionary Biology, University of Michigan, Ann Arbor, MI 48109, USA; Fogarty International Center, National Institutes of Health, Bethesda,MD 20892, USA; Center for the Study of Complex Systems, University of Michigan,Ann Arbor, MI 48109, USA
Pages 1319-1329 | Published online: 09 Jan 2014

References

  • Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis? Lancet Infect. Dis. 3(7), 413–418 (2003).
  • Gordon JE, Hood RI. Whooping cough and its epidemiological anomalies. Am. J. Med. Sci. 222(3), 333–361 (1951).
  • Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. Oxford University Press, Oxford, UK (1991).
  • Luttinger P. The epidemiology of pertussis. Am. J. Dis. Child 12, 290–315 (1916).
  • Rohani P, Drake JM. The decline and resurgence of pertussis in the US. Epidemics 3, 183–188 (2011).
  • Gangarosa EJ, Galazka AM, Wolfe CR et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet 351(9099), 356–361 (1998).
  • Baker JP. The pertussis vaccine controversy in Great Britain, 1974–1986. Vaccine 21, 4003–4010 (2003).
  • de Melker HE, Schellekens JF, Neppelenbroek SE, Mooi FR, Rümke HC, Conyn-van Spaendonck MA. Reemergence of pertussis in the highly vaccinated population of The Netherlands: observations on surveillance data. Emerg. Infect. Dis. 6, 348–357 (2000).
  • Skowronski DM, De Serres G, MacDonald D et al. The changing age and seasonal profile of pertussis in Canada. J. Infect. Dis. 185, 1448–1453 (2002).
  • Pebody RG, Gay NJ, Giammanco A et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol. Infect. 133(1), 159–171 (2005).
  • Dudman SG, Trøseid M, Jonassen TO, Steinbakk M. Kikhoste – et økende problem i Norge. Tidsskr Nor Lægeforen 3, 305–308 (2006).
  • Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE. Resurgence of Pertussis in Europe. J. Pediatr. Infect. Dis. 24, 761–765 (2005).
  • Lin YC, Yao SM, Yan JJ et al. Epidemiological shift in the prevalence of pertussis in Taiwan: implications for pertussis vaccination. J. Med. Microbiol. 56(Pt 4), 533–537 (2007).
  • Hozbor D, Mooi F, Flores D et al. Pertussis epidemiology in Argentina: trends over 2004–2007. J. Infect. 59(4), 225–231 (2009).
  • Cherry JD. The science and fiction of the ‘resurgence’ of pertussis. Pediatrics 112, 405–406 (2003).
  • Storsaeter J, Hallander HO, Gustafsson L, Olin P. Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis. Vaccine 21, 3542–3549 (2003).
  • Préziosi MP, Halloran ME. Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity. Clin. Infect. Dis. 37, 772–779 (2003).
  • Rohani P, Zhong X, King AA. Contact network structure explains the changing epidemiology of pertussis. Science 330(6006), 982–985 (2010).
  • Bisgard KM, Pascual FB, Ehresmann KR et al. Infant pertussis: who was the source? Pediatr. Infect. Dis. J. 23(11), 985–989 (2004).
  • De Greeff SC, Mooi FR, Westerhof A et al. Pertussis disease burden in the household: how to protect young infants. Clin. Infect. Dis. 50, 1339–1345 (2010).
  • Lavine J, Broutin H, Harvill ET, Bjørnstad ON. Imperfect vaccine-induced immunity and whooping cough transmission to infants. Vaccine 29, 11–16 (2010).
  • Keeling MJ, Rohani P. Modelling Infectious Diseases: in Humans and Animals. Princeton University Press, NJ, USA (2008).
  • Sutter RW, Cochi SL. Pertussis hospitalizations and mortality in the United States, 1985–1988. Evaluation of the completeness of national reporting. JAMA 267(3), 386–391 (1992).
  • Fine PE, Clarkson JA. The recurrence of whooping cough: possible implications for assessment of vaccine efficacy. Lancet 1(8273), 666–669 (1982).
  • Broutin H, Viboud C, Grenfell BT, Miller MA, Rohani P. Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries. Proc. Biol. Sci. 277(1698), 3239–3245 (2010).
  • Korobeinikov A, Maini PK, Walker WJ. Estimation of effective vaccination rate: pertussis in New Zealand as a case study. J. Theor. Biol. 224(2), 269–275 (2003).
  • Rohani P, Earn DJ, Grenfell BT. Impact of immunisation on pertussis transmission in England and Wales. Lancet 355(9200), 285–286 (2000).
  • Wearing HJ, Rohani P. Estimating the duration of pertussis immunity using epidemiological signatures. PLoS Pathog. 5, e1000647 (2009).
  • Rohani P, Keeling MJ, Grenfell BT. The interplay between determinism and stochasticity in childhood diseases. Am. Nat. 159, 469–481 (2002).
  • Bartlett MS. The critical community size for measles in the United States. J. Roy. Stat. Soc. Series A (General) 123, 37–44 (1960).
  • Conlan AJ, Rohani P, Lloyd AL, Keeling M, Grenfell BT. Resolving the impact of waiting time distributions on the persistence of measles. J. R. Soc. Interface 7, 623–640 (2010).
  • Broutin H, Simondon F, Guégan JF. Whooping cough metapopulation dynamics in tropical conditions: disease persistence and impact of vaccination. Proc. Biol. Sci. 271 (Suppl. 5), S302–S305 (2004).
  • Grenfell BT, Anderson RM. Pertussis in England and Wales: an investigation of transmission dynamics and control by mass vaccination. Proc. R. Soc. Lond., B, Biol. Sci. 236(1284), 213–252 (1989).
  • Wallinga J, Teunis P, Kretzschmar M. Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. Am. J. Epidemiol. 164, 936–944 (2006).
  • Lavine JS, King AA, Bjørnstad ON. Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. Proc. Natl Acad. Sci. USA 108(17), 7259–7264 (2011).
  • Yih WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989–1998. J. Infect. Dis. 182(5), 1409–1416 (2000).
  • Güris D, Strebel PM, Bardenheier B et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990–1996. Clin. Infect. Dis. 28(6), 1230–1237 (1999).
  • Brennan M, Strebel P, George H et al. Evidence for transmission of pertussis in schools, Massachusetts, 1996: epidemiologic data supported by pulsed-field gel electrophoresis studies. J. Infect. Dis. 181(1), 210–215 (2000).
  • Berger F, Njamkepo E, Minaberry S et al. Investigation on a pertussis outbreak in a military school: risk factors and approach to vaccine efficacy. Vaccine 28(32), 5147–5152 (2010).
  • van Boven M, de Melker HE, Schellekens JF, Kretzschmar M. Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands. Math. Biosci. 164, 161–182 (2000).
  • Mooi FR. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect. Genet. Evol. 10(1), 36–49 (2010).
  • Aguas R, Gonçalves G, Gomes MG. Pertussis: increasing disease as a consequence of reducing transmission. Lancet Infect. Dis. 6(2), 112–117 (2006).
  • Mossong J, Hens N, Jit M et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 5, e74 (2008).
  • Carlsson RM, Trollfors B. Control of pertussis–lessons learnt from a 10-year surveillance programme in Sweden. Vaccine 27(42), 5709–5718 (2009).
  • Préziosi MP, Halloran ME. Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness. Vaccine 21, 1853–1861 (2003).
  • Lavine JS, Bjørnstad ON, de Blasio BF, Storsaeter J. Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine. Vaccine 30(3), 544–551 (2012).
  • Schellekens J, von König CH, Gardner P. Pertussis sources of infection and routes of transmission in the vaccination era. Pediatr. Infect. Dis. J. 24, S19–S24 (2005).
  • Kermack WO, McKendrick AG. Contributions to the mathematical theory of epidemics–I. 1927. Bull. Math. Biol. 53(1–2), 33–55 (1991).
  • Wood SN. Statistical inference for noisy nonlinear ecological dynamic systems. Nature 466, 1–6 (2010).
  • Doucet A, De Freitas N, Gordon N. Sequential Monte Carlo methods in practice. Statistics for Engineering and Information Science. Springer, NY, USA (2001).
  • Ionides EL, Bhadra A, Atchade Y, King AA. Iterated Filtering. Ann. Stat. 39, 1776–1802 (2011).
  • King AA, Ionides EL, Bretó CM et al. Pomp: statistical inference for partially observed Markov processes. (R package) (2010).
  • R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria (2010).
  • Hernán MA, Wilcox AJ. Epidemiology, data sharing, and the challenge of scientific replication. Epidemiology 20, 167–168 (2009).
  • Hewlett EL, Halperin SA. Serological correlates of immunity to Bordetella pertussis. Vaccine 16(20), 1899–1900 (1998).
  • van Boven M, Mooi FR, Schellekens JF, de Melker HE, Kretzschmar M. Pathogen adaptation under imperfect vaccination: implications for pertussis. Proc. Biol. Sci. 272, 1617–1624 (2005).
  • Bokhari H, Said F, Syed MA et al. Whooping cough in Pakistan: Bordetella pertussis vs Bordetella parapertussis in 2005–2009. Scand. J. Infect. Dis. 43, 818–820 (2011).
  • Miranda C, Porte L, García P. Bordetella holmesii in nasopharyngeal samples from Chilean patients with suspected Bordetella pertussis infection. J. Clin. Microbiol. 50, 1505 (2012).
  • Njamkepo E, Bonacorsi S, Debruyne M, Gibaud SA, Guillot S, Guiso N. Significant finding of Bordetella holmesii DNA in nasopharyngeal samples from French patients with suspected pertussis. J. Clin. Microbiol. 49, 4347–4348 (2011).
  • Eames KT, Tilston NL, Brooks-Pollock E, Edmunds WJ. Measured dynamic social contact patterns explain the spread of H1N1v influenza. PLoS Comput. Biol. 8, e1002425 (2012).
  • Simpson DM, Ezzati-Rice TM, Zell ER. Forty years and four surveys: how does our measuring measure up? Am. J. Prev. Med. 20(Suppl. 4), 6–14 (2001).
  • Metcalf CJ, Bjørnstad ON, Grenfell BT, Andreasen V. Seasonality and comparative dynamics of six childhood infections in pre-vaccination Copenhagen. Proc. Biol. Sci. 276(1676), 4111–4118 (2009).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.